START and Trialing Partner to Boost Oncology Clinical Trial Access in Europe
Event summary
- The START Center for Cancer Research partners with Trialing to expand access to oncology clinical trials across Europe.
- Collaboration aims to enhance physician awareness, streamline referrals, and support patient access to early-phase oncology research.
- START will distribute curated trial information via Trialing's platform, providing real-time updates and enrollment notifications.
- Trialing's physician-driven platform connects oncologists, hospitals, patients, and pharmaceutical sponsors through structured trial intelligence.
The big picture
This partnership aligns with broader industry trends toward digital transformation in clinical trials, aiming to reduce barriers to patient participation. By leveraging Trialing's platform, START seeks to modernize trial access, strengthen physician engagement, and accelerate oncology research across Europe. The collaboration reflects a strategic shift towards more connected, technology-driven solutions in the clinical trial space.
What we're watching
- Physician Engagement
- How effectively START and Trialing can engage physicians through the platform to increase trial awareness and referrals.
- Trial Access Expansion
- The pace at which this partnership will expand patient access to early-phase oncology trials across Europe.
- Technology Integration
- Whether Trialing's AI-supported screening capabilities can further streamline the trial referral process and reduce participation barriers.
Related topics